Pfizer Inc.
PFE
$25.94
$0.190.74%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
Weiss Ratings | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | C+ | |||
Rating Factors | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Excellent | |||
Growth Index | Weak | |||
Efficiency Index | Good | |||
Solvency Index | Good | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.30 | |||
Price History | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -2.99% | |||
30-Day Total Return | -0.27% | |||
60-Day Total Return | 0.95% | |||
90-Day Total Return | -10.44% | |||
Year to Date Total Return | -2.56% | |||
1-Year Total Return | -4.89% | |||
2-Year Total Return | -41.23% | |||
3-Year Total Return | -53.07% | |||
5-Year Total Return | -34.12% | |||
52-Week High % Change | -17.76% | |||
52-Week Low % Change | 5.96% | |||
Price | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $31.54 | |||
52-Week Low Price | $24.48 | |||
52-Week Low Price (Date) | Nov 15, 2024 | |||
52-Week High Price (Date) | Jul 30, 2024 | |||
Valuation | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 147.01B | |||
Enterprise Value | 194.25B | |||
Price/Earnings (TTM) | 18.32 | |||
Earnings Per Share (TTM) | 1.42 | |||
Earnings Per Share Growth | 297.64% | |||
Price/Earnings To Growth | 0.06 | |||
Price/Sales (TTM) | 2.33 | |||
Price/Book (Q) | 1.67 | |||
Enterprise Value/Revenue (TTM) | 3.05 | |||
Price | $25.94 | |||
Enterprise Value/EBITDA (TTM) | 8.32 | |||
Enterprise Value/EBIT | 11.89 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 5.70B | |||
Dividend Yield | 6.52% | |||
Div. Per Share (Most Recent) | $0.43 | |||
Dividend Per Share (TTM) | $1.69 | |||
Payout Ratio (TTM) | 118.44% | |||
Dividend Per Share (Most Recent) | $0.43 | |||
Company Info | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 212 733 2323 | |||
Address | 66 Hudson Boulevard East New York, NY 10001-2192 | |||
Website | www.pfizer.com | |||
Country | United States | |||
Year Founded | 1849 | |||
Profitability | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 25.68% | |||
Profit Margin | 12.62% | |||
Management Effectiveness | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 4.64% | |||
Return on Equity | 9.06% | |||
Income Statement | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 63.63B | |||
Total Revenue (TTM) | 63.63B | |||
Revenue Per Share | $11.16 | |||
Gross Profit (TTM) | 47.21B | |||
EBITDA (TTM) | 23.34B | |||
EBIT (TTM) | 16.34B | |||
Net Income (TTM) | 8.03B | |||
Net Income Avl. to Common (TTM) | 8.03B | |||
Total Revenue Growth (Q YOY) | 21.92% | |||
Earnings Growth (Q YOY) | 112.33% | |||
EPS Diluted (TTM) | 1.42 | |||
EPS Diluted Growth (Q YOY) | 111.86% | |||
Balance Sheet | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 20.48B | |||
Cash Per Share (Q) | $3.59 | |||
Total Current Assets (Q) | 50.36B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 88.50B | |||
Current Ratio (Q) | 1.171 | |||
Book Value Per Share (Q) | $15.56 | |||
Total Assets (Q) | 213.40B | |||
Total Current Liabilities (Q) | 43.00B | |||
Total Debt (Q) | 67.42B | |||
Total Liabilities (Q) | 124.90B | |||
Total Common Equity (Q) | 88.20B | |||
Cash Flow | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 2.65B | |||
Cash from Financing (TTM) | -17.14B | |||
Net Change in Cash (TTM) | -1.81B | |||
Levered Free Cash Flow (TTM) | 12.31B | |||
Cash from Operations (TTM) | 12.74B | |||